Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon

PHASE3CompletedINTERVENTIONAL
Enrollment

816

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Malaria
Interventions
DRUG

1. Artemether-Lumefantrine (AL)

Artemether-Lumefantrine(Co-Artem)=Artemether, 2mg/kg x 2(12h apart) and Lumefantrine, 12mg/kgx2 (12h apart).

DRUG

2. Amodiaquine-Artesunate (AQ-AS)

Amodiaquine-Artesunate (0H),D1(24H),D2(48H)= Artesunate 4mg/kg and Amodiaquine at 10mg/kg

All Listed Sponsors
collaborator

University of Yaounde

OTHER

collaborator

Cameroon Baptist Convention Health

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00297882 - Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon | Biotech Hunter | Biotech Hunter